Capstone Investment Advisors LLC Buys 29,230 Shares of Core Scientific, Inc. (NASDAQ:CORZ)

Capstone Investment Advisors LLC grew its stake in Core Scientific, Inc. (NASDAQ:CORZ) by 113.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 55,000 shares of the company’s stock after buying an additional 29,230 shares during the quarter. Capstone Investment Advisors LLC’s holdings in Core Scientific were worth $652,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Taconic Capital Advisors LP raised its position in shares of Core Scientific by 178.7% during the 3rd quarter. Taconic Capital Advisors LP now owns 2,717,462 shares of the company’s stock valued at $32,229,000 after purchasing an additional 1,742,462 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in shares of Core Scientific in the third quarter worth about $2,651,000. Zurcher Kantonalbank Zurich Cantonalbank bought a new position in shares of Core Scientific in the third quarter worth about $348,000. MetLife Investment Management LLC grew its position in shares of Core Scientific by 129.1% during the third quarter. MetLife Investment Management LLC now owns 103,583 shares of the company’s stock worth $1,228,000 after purchasing an additional 58,365 shares in the last quarter. Finally, Corsair Capital Management L.P. raised its stake in Core Scientific by 62.9% during the 3rd quarter. Corsair Capital Management L.P. now owns 32,364 shares of the company’s stock valued at $384,000 after purchasing an additional 12,500 shares during the period.

Analysts Set New Price Targets

Several research analysts have weighed in on CORZ shares. Canaccord Genuity Group began coverage on Core Scientific in a research note on Monday, September 23rd. They issued a “buy” rating and a $16.00 price target for the company. Macquarie upped their target price on shares of Core Scientific from $16.00 to $19.00 and gave the stock an “outperform” rating in a research report on Thursday, November 14th. Canaccord Genuity Group reiterated a “buy” rating and issued a $17.00 price target on shares of Core Scientific in a report on Thursday, November 7th. Sanford C. Bernstein reiterated an “outperform” rating and issued a $17.00 price target on shares of Core Scientific in a research note on Tuesday, September 10th. Finally, Roth Mkm began coverage on Core Scientific in a research report on Friday, November 15th. They set a “buy” rating and a $25.50 price objective for the company. Thirteen equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $18.38.

Insider Transactions at Core Scientific

In other news, Director Jarrod M. Patten acquired 5,021 shares of the business’s stock in a transaction on Tuesday, September 3rd. The shares were acquired at an average price of $9.68 per share, for a total transaction of $48,603.28. Following the completion of the transaction, the director now directly owns 285,760 shares of the company’s stock, valued at approximately $2,766,156.80. The trade was a 1.79 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Yadin Rozov sold 105,000 shares of the firm’s stock in a transaction dated Friday, November 22nd. The stock was sold at an average price of $18.11, for a total transaction of $1,901,550.00. Following the completion of the sale, the director now owns 345,239 shares of the company’s stock, valued at $6,252,278.29. This trade represents a 23.32 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 32.00% of the company’s stock.

Core Scientific Price Performance

Shares of NASDAQ CORZ opened at $17.88 on Friday. Core Scientific, Inc. has a 1-year low of $2.61 and a 1-year high of $18.63. The business’s 50 day moving average is $14.27 and its two-hundred day moving average is $10.81. The stock has a market capitalization of $4.99 billion and a P/E ratio of -3.30.

Core Scientific Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.